BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26304928)

  • 1. Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients.
    Jia X; Liu G; Mo M; Cheng J; Shen Z; Shao Z
    Oncotarget; 2015 Sep; 6(27):24571-80. PubMed ID: 26304928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
    Ritte R; Tikk K; Lukanova A; Tjønneland A; Olsen A; Overvad K; Dossus L; Fournier A; Clavel-Chapelon F; Grote V; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Berrino F; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Buckland G; Molina-Montes E; Chirlaque MD; Ardanaz E; Amiano P; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Wareham N; Khaw KT; Key TJ; Travis RC; Weiderpass E; Dumeaux V; Lund E; Sund M; Andersson A; Romieu I; Rinaldi S; Vineis P; Merritt MA; Riboli E; Kaaks R
    BMC Cancer; 2013 Dec; 13():584. PubMed ID: 24321460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study.
    Chung S; Park SK; Sung H; Song N; Han W; Noh DY; Ahn SH; Yoo KY; Choi JY; Kang D
    Breast Cancer Res Treat; 2013 Aug; 140(3):557-65. PubMed ID: 23901017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and breast cancer.
    Kalache A; McPherson K; Barltrop K; Vessey MP
    Br J Hosp Med; 1983 Oct; 30(4):278-83. PubMed ID: 6640197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer.
    Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Stefanick ML; Vitolins M; Kabat GC; Rohan TE; Li CI
    J Natl Cancer Inst; 2011 Mar; 103(6):470-7. PubMed ID: 21346227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.
    Ma H; Bernstein L; Pike MC; Ursin G
    Breast Cancer Res; 2006; 8(4):R43. PubMed ID: 16859501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.
    Rosato V; Bosetti C; Negri E; Talamini R; Dal Maso L; Malvezzi M; Falcini F; Montella M; La Vecchia C
    Eur J Cancer Prev; 2014 Sep; 23(5):412-7. PubMed ID: 23817433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive factors and breast cancer.
    Kelsey JL; Gammon MD; John EM
    Epidemiol Rev; 1993; 15(1):36-47. PubMed ID: 8405211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of epidemiological factors by breast tumor subtypes in Korean women: a case-case study.
    Song N; Choi JY; Sung H; Chung S; Song M; Park SK; Han W; Lee JW; Kim MK; Yoo KY; Ahn SH; Noh DY; Kang D
    Int J Cancer; 2014 Aug; 135(3):669-81. PubMed ID: 24916400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival.
    Song N; Choi JY; Sung H; Jeon S; Chung S; Song M; Park SK; Han W; Lee JW; Kim MK; Yoo KY; Ahn SH; Noh DY; Kang D
    PLoS One; 2015; 10(4):e0123994. PubMed ID: 25875532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and significance of oestrogen receptor (ER) positivity in breast cancer at the University Hospital of the West Indies, Jamaica.
    Alfred R; Chin SN; Williams E; Walters C; Barton EN; Shah D
    West Indian Med J; 2012 Nov; 61(8):795-801. PubMed ID: 23757900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive history and breast cancer survival: a prospective patient cohort study in Japan.
    Minami Y; Nishino Y; Kawai M; Tada H; Kanemura S; Miyashita M; Ishida T; Kakugawa Y
    Breast Cancer; 2019 Nov; 26(6):687-702. PubMed ID: 30993643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of breast cancer in relation to reproductive factors in Denmark.
    Ewertz M; Duffy SW
    Br J Cancer; 1988 Jul; 58(1):99-104. PubMed ID: 3166899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities study.
    John EM; Phipps AI; Hines LM; Koo J; Ingles SA; Baumgartner KB; Slattery ML; Wu AH
    Int J Cancer; 2020 Oct; 147(7):1808-1822. PubMed ID: 32064598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of breast cancer in Tianjin, China.
    Wang QS; Ross RK; Yu MC; Ning JP; Henderson BE; Kimm HT
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):435-9. PubMed ID: 1302554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case-control study.
    Figueroa JD; Davis Lynn BC; Edusei L; Titiloye N; Adjei E; Clegg-Lamptey JN; Yarney J; Wiafe-Addai B; Awuah B; Duggan MA; Wiafe S; Nyarko K; Aitpillah F; Ansong D; Hewitt SM; Ahearn T; Garcia-Closas M; Brinton LA;
    Int J Cancer; 2020 Sep; 147(6):1535-1547. PubMed ID: 32068253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.
    McTiernan A; Thomas DB; Johnson LK; Roseman D
    J Natl Cancer Inst; 1986 Oct; 77(4):849-54. PubMed ID: 3463818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.
    Li CI; Beaber EF; Tang MT; Porter PL; Daling JR; Malone KE
    Breast Cancer Res Treat; 2013 Jan; 137(2):579-87. PubMed ID: 23224237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.